3202 | Salvinorin a(p)(2S,4aR,6aR,7R,9S,10aS,10bR)-9-(Acetyloxy)-2-(3-furanyl)dodecahydro-6a,10b-dimethyl-4,10-dioxo-2H-naphtho[2,1-c]pyran-7-carboxylic acid methyl ester, (2S,4aR,6aR,7R,9S,10aS,10bR)-9-(acetyloxy)-2-(3-furanyl)dodechydro-6a,10b-dimethyl-4,10-dioxo-2H-naphtho[2,1-c]pyran-7-carboxylic acid methyl ester, Divinorin A, Salvinorin, [2S-(2α,4aα,6aβ,7β,9β,10aα,10bβ)]-9-(Acetyloxy)-2-(3-furanyl)dodecahydro-6a,10b-diMethyl-4,10-dioxo-2H-naphtho[2,1-c]pyran-7-carboxylic Acid Methyl Ester | | Pharmaceutical Affairs Law | Designated Substances | | Prohibition of manufacture and import of pharmaceutical products, non-pharmaceutical products and medical devices without a permit from Minister for Health, Labour and Welfare | Ministry of Health, Labour and Welfare | | Pharmaceutical Affairs Law |